Supporting the adoption of new innovations into the NHS
The Artificial Intelligence (AI) Award is an NHS AI Lab programme run by the Accelerated Access Collaborative (AAC) in partnership with the NIHR. It will accelerate the testing and evaluation of AI technologies. The awards support technologies at various stages of development, from initial feasibility to evaluation within the NHS.
The Early Access Medicines Scheme (EAMS) aims to give patients with life threatening or seriously debilitating conditions access to medicines that do not yet have a marketing authorisation.
The MedTech Funding Mandate from the AAC aims to direct healthcare providers and commissioners within NHS organisations towards cost-effective MedTech innovations that have been recommended by NICE diagnostics guidance, or medical technologies guidance.